PL396696A1 - Preparat farmaceutyczny i/lub kosmetyczny - Google Patents

Preparat farmaceutyczny i/lub kosmetyczny

Info

Publication number
PL396696A1
PL396696A1 PL396696A PL39669600A PL396696A1 PL 396696 A1 PL396696 A1 PL 396696A1 PL 396696 A PL396696 A PL 396696A PL 39669600 A PL39669600 A PL 39669600A PL 396696 A1 PL396696 A1 PL 396696A1
Authority
PL
Poland
Prior art keywords
alkyl
pharmaceutical
cosmetic preparation
formula
disclosed
Prior art date
Application number
PL396696A
Other languages
English (en)
Inventor
Jerzy Gębicki
Anna Sysa-Jędrzejowska
Jan Adamus
Original Assignee
Pharmena Spółka Akcyjna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmena Spółka Akcyjna filed Critical Pharmena Spółka Akcyjna
Priority to PL396696A priority Critical patent/PL396696A1/pl
Publication of PL396696A1 publication Critical patent/PL396696A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL396696A 1999-01-07 2000-01-07 Preparat farmaceutyczny i/lub kosmetyczny PL396696A1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL396696A PL396696A1 (pl) 1999-01-07 2000-01-07 Preparat farmaceutyczny i/lub kosmetyczny

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL330768A PL190755B1 (pl) 1999-01-07 1999-01-07 Preparat do leczenia i profilaktyki chorób skóry
PL396696A PL396696A1 (pl) 1999-01-07 2000-01-07 Preparat farmaceutyczny i/lub kosmetyczny

Publications (1)

Publication Number Publication Date
PL396696A1 true PL396696A1 (pl) 2012-01-16

Family

ID=20073560

Family Applications (2)

Application Number Title Priority Date Filing Date
PL330768A PL190755B1 (pl) 1999-01-07 1999-01-07 Preparat do leczenia i profilaktyki chorób skóry
PL396696A PL396696A1 (pl) 1999-01-07 2000-01-07 Preparat farmaceutyczny i/lub kosmetyczny

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL330768A PL190755B1 (pl) 1999-01-07 1999-01-07 Preparat do leczenia i profilaktyki chorób skóry

Country Status (12)

Country Link
EP (1) EP1147086B9 (pl)
AT (1) ATE292117T1 (pl)
AU (1) AU1792700A (pl)
CZ (1) CZ299662B6 (pl)
DE (1) DE60019086T2 (pl)
ES (1) ES2238985T3 (pl)
HU (1) HU225475B1 (pl)
PL (2) PL190755B1 (pl)
RU (1) RU2199319C1 (pl)
SK (1) SK285869B6 (pl)
UA (1) UA73491C2 (pl)
WO (1) WO2000040559A1 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ303214B6 (cs) * 2001-03-21 2012-05-30 Torrent Pharmaceuticals Ltd Pyridiniová sloucenina, zpusob její výroby, její použití, farmaceutický prostredek ji obsahující, zpusob jeho výroby a jeho použití
PL364348A1 (pl) 2004-01-12 2005-07-25 PHARMENA Sp.z o.o. Zastosowanie czwartorzędowych soli pirydyniowych jako środka naczynioprotekcyjnego
DE102004013798A1 (de) * 2004-03-20 2005-10-06 Wella Aktiengesellschaft Verwendung von Mitteln zur kosmetischen Behandlung von Keratin enthaltenden Material
CA2614885C (en) 2005-07-11 2015-03-17 Pharmena North America Inc. Methylnicotinamide derivatives and formulations for treatment of lipoprotein abnormalities
MX2008007259A (es) * 2005-12-09 2008-09-23 Cerecon Ag Sales cuaternarias de 3-amido, n-metilpiridinio como agentes antiinflamatorios.
PL2026651T3 (pl) * 2006-03-08 2013-06-28 Cortria Corp Terapia kombinowana za pomocą nieselektywnych inhibitorów COX dla zapobiegania uszkodzeń żołądka związanych z COX
WO2008062324A2 (en) * 2006-10-11 2008-05-29 Dermena Compositions comprising nicotinamide and wakame extract having skin anti-aging properties
JP2010506900A (ja) * 2006-10-18 2010-03-04 デルメナ リポ蛋白質異常症並びに皮膚疾病および皮膚障害の処置のためのｎ−メチルニコチンアミドを含有する食品抽出物
WO2009063493A2 (en) * 2007-09-10 2009-05-22 Glenmark Pharmaceuticals Limited Topical pharmaceutical composition for the combination of fusidic acid and a corticosteroid
EP2211858B1 (en) 2007-10-12 2015-03-25 Politechnika Lodzka Use of quaternary pyridinium salts for inhibiting cancer metastases
TWI432188B (zh) * 2008-12-19 2014-04-01 Merz Pharma Gmbh & Co Kgaa 供治療發炎性皮膚疾病之１－胺基－烷基環己烷衍生物類
WO2018015862A1 (en) 2016-07-18 2018-01-25 Pharmena S.A. 1-methylnicotinamide salts for use in raising the blood levels of adiponectin
CA3146376A1 (en) 2019-07-12 2021-01-21 Unilever Global Ip Limited Bioenergetic combinations and methods of using same
WO2021205341A1 (en) 2020-04-07 2021-10-14 Pharmena S.A. 1-methylnicotinamide for the prevention/treatment of inflammatory airway diseases
PL444846A1 (pl) * 2023-05-10 2024-03-11 Politechnika Poznańska Sposób otrzymywania czwartorzędowych soli amoniowych z kationem 3-karbamoilo-1-alkilopirydyniowym i anionem salicylanowym

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3823076A (en) * 1972-05-23 1974-07-09 Du Pont Zinc electroplating additive
US4067975A (en) * 1975-08-04 1978-01-10 Yu Ruey J Treatment of psoriasis with 6-aminonicotinamide and thionicotinamide
US4505896A (en) * 1979-04-19 1985-03-19 Elorac, Ltd. Method of treating acne vulgaris and composition
US4578394A (en) * 1984-12-10 1986-03-25 Hoechst-Roussel Pharmaceuticals Incorporated Cholinergic function increasing 3-[N-(pyridyl) carbamoyl]-1,4-dihydropyridines
DE3603601C3 (de) * 1986-02-06 1999-12-23 Jutta Mai Verwendung eines Bockshornkleesamenextraktes
US4786647A (en) * 1986-06-30 1988-11-22 University Of Florida Method for eliciting anxiolysis
US5372911A (en) * 1991-06-13 1994-12-13 Dainippon Ink And Chemicals, Inc. Process of forming super high-contrast negative images and silver halide photographic material and developer being used therefor
WO1998052927A1 (en) * 1997-05-19 1998-11-26 Rosemarie Scivoletto Composition for treating skin conditions

Also Published As

Publication number Publication date
DE60019086D1 (de) 2005-05-04
HUP0104963A2 (hu) 2002-04-29
ATE292117T1 (de) 2005-04-15
DE60019086T2 (de) 2006-02-02
WO2000040559A1 (en) 2000-07-13
RU2001121650A (ru) 2004-02-27
PL190755B1 (pl) 2006-01-31
SK9512001A3 (en) 2001-12-03
HUP0104963A3 (en) 2002-11-28
HU225475B1 (en) 2006-12-28
PL330768A1 (en) 2000-07-17
UA73491C2 (uk) 2005-08-15
AU1792700A (en) 2000-07-24
EP1147086B9 (en) 2010-09-22
ES2238985T3 (es) 2005-09-16
SK285869B6 (sk) 2007-10-04
EP1147086A1 (en) 2001-10-24
RU2199319C1 (ru) 2003-02-27
EP1147086B1 (en) 2005-03-30
ES2238985T9 (es) 2011-03-24
CZ299662B6 (cs) 2008-10-08
CZ20012450A3 (cs) 2002-10-16

Similar Documents

Publication Publication Date Title
PL396696A1 (pl) Preparat farmaceutyczny i/lub kosmetyczny
HUT71889A (en) Pharmaceutical compositions containing terfenadine metabolites and their optically pure isomers for treating allergic disorders
CA2332389A1 (en) Liposomal preparations for the application of antiseptic agents to the interior of the body
SE9604786D0 (sv) New compounds
TR200001840T2 (tr) Arile bağlı azopolisiklik bileşikler
HUP0401192A2 (hu) Fényérzékenyítő szer alkalmazása sebek kezelésére adható gyógyászati készítmény előállítására
AU2001270554A1 (en) Use of an (r)-enantiomer of lipoic acid in cosmetics and dermatologicals
AU2003263878A1 (en) Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents
MX9501848A (es) Nuevos compuestos polienicos, composiciones farmaceuticas y cosmeticas que los contienen y sus usos.
AU2108500A (en) Galenic formulation containing biotin
KR960000855A (ko) L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제조성물
KR960010002A (ko) L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제 조성물
ES2194055T3 (es) Nuevo uso de prostaglandinas.
CA2417935A1 (en) Anti-inflammatory medicament
GEP20043202B (en) Resorcinol Derivatives
CA2340734A1 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases
KR960010003A (ko) L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제 조성물
GEP20043231B (en) Resorcinol Composition
AU2173101A (en) Use of carboxy compounds such as 2(4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride as anti-inflammatory agents
TR199900013T2 (xx) Yeni bile�ikler.
US6288112B1 (en) Use of pyrethroid compounds to promote hair growth
DE69511247D1 (de) Therapeutische benzonitrile
ITMI942645A1 (it) Uso di derivati guanidin-imidazolici per coadiuvare la stimolazione della crescita dei capelli.
AU2030597A (en) Bicyclic-aromatic compounds
JO1679B1 (en) A new, therapeutically active compound and method for preparing it

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)